Thirty states have reached an $8 million settlement with Bayer Corp. over allegations the drug maker failed to adequately warn consumers about risks associated with the cholesterol-reducing drug Baycol. Bayer has not admitted wrongdoing, but has agreed to register relevant clinical drug trials and drug studies and to post the results online. The company also is barred from making false or misleading claims in the future marketing and sale of its products. Bayer withdrew Baycol from the market in 2001.
Popularity: 1% [?]
Posted on Thursday, January 25th, 2007. Filed under: Business Law, Law Misc
You can leave a response, or trackback from your own site.